¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tracer disease method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® rheumatic heart disease ÇÑ±Û ·ù¸¶Æ¼½º½ÉÀ庴
¼³¸í   
  »ç½½¾Ë±Õ°¨¿° ÈÄ »ý±â´Â ½ÉÀåÆÇ¸·º´ÀÌ´Ù. ¿øÀÎÀº A±º -¿ëÇ÷»ç½½¾Ë¿¡ ÀÇÇÑ Àεο°ÈÄ ÀÏÁ¾ÀÇ ¸é¿ª¹ÝÀÀÀ¸·Î ¹ßº´ÇÑ´Ù.
  
  Áø´ÜÀº Á¸ÀÇ ±âÁØ¿¡ ÀÇÇÑ´Ù.
  
  (1) ÁÖ¿ä±âÁØÀº °üÀý¿° ½ÉÀå¿°(½ÉÀåºñ´ë, ½ÉÀåÀâÀ½, ½ÉÀå±â´É»ó½Ç µî) ¹«µµÁõ: ¹«´çÀÌ ÃãÀ» Ãߴ °Í °°Àº ÇൿÀÇ ¹ßÀÛÁõ¼¼. ¿¬º¯È«¹Ý: »¡°£ Å׵θ®¸¦ °¡Áø ÇǺκ´º¯Àº ÇÇÇϰáÀý(subcutaneous nodule): ÇǺΠ¹Ø¿¡ »ý±ä °áÀý,
  
  (2)Âü°í ±âÁØÀº ¿­, °üÀýÅë, EKG»ó PR¿¬Àå: ½ÉÀüµµ ¼Ò°ß ±Þ¼º±â ¹ÝÀÀ¹°Áú(¿¹: ESR, CRP)ÀÇ »ó½Â, ·ù¸¶Æ¼½º¿­
  
  Ä¡·á´Â Æä´Ï½Ç¸°À¸·Î Ä¡·áÇÏ°í ½ÉÀåÀÇ ÈÄÀ¯Áõ ¶ÇÇÑ Æä´Ï½Ç¸°À¸·Î ¿¹¹æÇÑ´Ù.
¿µ¹® chronic obstructive pulmonary disease ÇÑ±Û ¸¸¼ºÆó¼âÆóº´
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö Ãµ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù.
  
  ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í À̷ΠÀÎÇØ¼­ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼­ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀ̠Ǫ¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³­´Ù.
  
  Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇϰԠÆìÁö´Â °ÍÀ» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿­µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù.
  
  ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼­ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼­ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀΠÆó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼­´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼­ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. 
¿µ¹® Buerger disease ÇÑ±Û ¹ö°Åº´
¼³¸í   
  ¸»ÃÊ µ¿¸Æ°ú Á¤¸Æ¿¡ ¿°ÁõÀ» ÀÏÀ¸Å°´Â º´. Ã»Àå³âÃþÀÇ ³²ÀÚ¿¡°Ô Àß °É¸®´Â ´Ù¸® µ¿¸Æ¿¡ »ý±â´Â º´À¸·Î µ¿¸ÆÀÌ ¸·È÷°í ÅëÁõ ¶§¹®¿¡ ¹ßÀ» Àý±âµµ Çϴµ¥ ¿øÀÎÀº ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù. º´¸íÀº ÀÌ º´À» ÃÖÃʷΠ»ó¼¼ÇϰԠº¸°íÇÑ ¹Ì±¹ÀÇ ÀÇ»ç L. ¹ö°Å(1879~1943)ÀÇ À̸§¿¡¼­ ¿¬À¯ÇÑ´Ù. µ¿¾çÀο¡°Ô ¸¹Àº º´À¸·Î, ´ëºÎºÐ ÀþÀº ³²¼º, Æ¯È÷ Àå³â±â ³²¼º¿¡°Ô¼­ ³ªÅ¸³­´Ù. ¿øÀÎÀº ¾Ë ¼ö ¾øÀ¸³ª Èí¿¬ÀÌ º´ÀÇ ¾ÇÈ­¸¦ ÃÊ·¡ÇÑ´Ù. »çÁöÀÇ µ¿¸Æ°ú Á¤¸Æ¿¡ ¿°ÁõÀÌ ÀϾ Ç÷ÀüÀÌ »ý±â¸é ³»°­À» ¸·¾Æ Ç÷¾×ÀÌ È帣Áö ¸øÇϰԠµÇ¾î ±× ¾ÕÀÇ ¸»ÃÊÁ¶Á÷ÀÌ ±«»ç¿¡ ºüÁö°Å³ª ¼Õ¹ßÀÌ Â÷°©°í, ¼Õ°¡¶ô-¹ß°¡¶ôÀÌ º¸¶ó»ö ¶Ç´Â °ËÀº»öÀ¸·Î º¯ÇÑ´Ù. ¶Ç, ÀÌ Áõ¼¼°¡ °è¼ÓµÇ´Â µ¿¾È ¼Õ¹ß°¡¶ô¿¡ ÅëÁõÀÌ ÀϾ°í ±Ë¾çÀÌ ¹ß»ýÇÑ´Ù. Ä¡·á´Â Áõ¼¼ÀÇ Á¤µµ¿Í Æó»öµÈ Ç÷°üÀÇ ºÎÀ§¿¡ µû¶ó ¿¬°í¸¦ ¹Ù¸£°Å³ª Ç÷°üÈ®ÀåÁ¦-¼øÈ¯°³¼±Á¦-Ç÷¼ÒÆÇÀÀÁý¾ïÁ¦Á¦¸¦ »ç¿ëÇϳª, ¾î¶² Ä¡·áµµ È¿°ú°¡ ¾øÀ» °æ¿ì ¼Õ¹ß°¡¶ôÀÇ ¼ÒÀý´Ü, µå¹°°Ô´Â ¹«¸­ ÀÌÇÏÀÇ ´ëÀý´ÜÀ» ÇؾߠÇÑ´Ù. ÀϹÝÀûÀ¸·Î ÀÌ º´ÀÇ ¿¹ÈĴ ¾çÈ£ÇÏ¿© Ç÷·ù°¡ È¸º¹µÇ°í ±Ë¾ç¸¸ Ä¡·áµÇ¸é Àç¹ßÀÌ Àû´Ù.
¿µ¹® Behcet disease ÇÑ±Û º£Ã¼Æ®º´
¼³¸í   
  ½ÉÇÑ Æ÷µµ¸·¿°, ¸Á¸·Ç÷°ü¿°, ½Ã°¢½Å°æÀ§Ãà, ±¸°­-¼º±âÀÇ ¾ÆÇÁŸ¼º ±Ë¾ç, ±¤¹üÀ§ÇÑ Ç÷°ü¿°ÀǠ¡ÈĿ͠Áõ»óÀ» ³ªÅ¸³½´Ù. ¿øÀκҸíÀÇ Èñ±ÍÇÑ º´À¸·Î ÀþÀº ³²ÀÚ¿¡°Ô Àß ¹ß»ýÇÑ´Ù.
¿µ¹® congenital heart disease ÇÑ±Û ¼±Ãµ½ÉÀ庴
¼³¸í   
  ¼±ÃµÀûÀ¸·Î ½ÉÀåÀÇ ±¸Á¶¿¡ ÀÌ»óÀÌ Àִ º´.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Black method
    ºí·¢¹æ¹ý
  • blind method
    ´«°¡¸²¹ý
  • bolus-tracking method
    µ¢¾î¸®ÃßÀû¹æ¹ý
  • brine flotation method
    ½Ä¿°¼öºÎÀ¯¹ý
  • candle jar method
    ÃкҺ´¹è¾ç¹ý
  • capillary tube method
    ¸ð¼¼½ÃÇè°ü¹ý
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • capture-recapture method
    Æ÷ȹÀçÆ÷ȹ¹ý
  • comparative method
    ºñ±³¹ý
  • compensation method
    º¸»ó¹ý
  • convergent method
    ¼ö·ÅÁ¶»ç¹ý
  • cough plate method
    ±âħÆòÆÇ¹ý
  • cup cylinder method
    ¿øÅë¹ý
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
  • checkerboard method
    ¹ÙµÏÆÇ¹æ¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Crohn's disease
    Å©·Ðº´
  • Cushing's disease
    Äí½Ìº´
  • de Quervain's disease
    µåÄõº£Àκ´
  • degenerative disease
    ÅðÇິ
  • fibrocystic disease
    ¼¶À¯³¶º´
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
  • Hashimoto's disease
    ÇϽøðÅ亴
  • Hirschsprung's disease
    (¢¡ congenital megacolon) È÷¸£½´½´ÇÁ·îº´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • infectious disease
    °¨¿°º´
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ
  • inherited disease
    À¯Àüº´
  • Legg-Calve-Perthes disease
    (¢¡ostetochondrosis of the capitualar epiphysis of th) ·¹±×Ä®º£Æä¸£Å×½ºº´, ³Ò´Ù¸®»À¸Ó¸®»À³¡»À¿¬°ñÁõ
  • life style disease
    »ýȰ½À°üº´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý
  • analytical method
    ºÐ¼®¹ý
  • ascending method
    »ó½Â¹ý
  • aspirative irrigation method
    ÈíÀμ¼Ã´¹ý
  • auscultatory method
    ûÁø¹ý
  • bioassay method
    »ý¹°ÇÐÀû°ËÁ¤¹ý
  • bisecting method
    À̵îºÐ¸é¹ý
  • black method
    ºí·¢¹æ¹ý
  • bolus-tracking method
    µ¢¾î¸®ÃßÀû¹æ¹ý
  • brine flotation method
    ½Ä¿°¼öºÎÀ¯¹ý
  • candle jar method
    ÃкҺ´¹è¾ç¹ý
  • capillary tube method
    ¸ð¼¼½ÃÇè°ü¹ý
  • cava pocket method
    ´ëÁ¤¸ÆÆ÷ÄϹý
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • checkerboard method
    ¹ÙµÏÆÇ¹æ¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Halsteds method (operation)
    Ȧ½ºÅ×µå ¼ö¼ú.
  • Hegar s method =H s operation
    Çì°¡¼ö ¼ú.
  • India ink method
    ¸Ô¹°°æ°Ë¹ý
  • Indian ink method
    ¸Ô¹°µµ¸»¹ý
  • Kay-Bodansky method
    Ä«ÀÌ-º¸´Ü½ºÅ°¹ý
  • King-Armstrong method
    Å·-¾Ï½ºÆ®·Õ¹ý
  • Lod score method
    ·ÎµåÁ¡¼ö¹ý
  • Lyman s method
    ¶óÀ̸¸¹ý.
  • Maitlands culture method
    ¸¶ÀÌÆ®·£µå¹è¾ç¹ý
  • Mancini method
    ¸¸½Ã´Ï¹ý
  • Octoson scanning method
    ¿ÁÅä¼Õ ½ºÄµ¹ý (Ûö)
  • Proetz displacement method
    ÇÁ·ÚÃ÷ġȯ¹ý
  • Quellung method
    ÆØÃ¢¹ý(ø³óìÛö).
  • Quellung method
    ÆØÃ¢¹ý(ø³óìÛö).
  • Rothera method
    ·ÎÅ×¶ó¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • agar filtration method
    ÇÑõ°Å¸£±â(¹ý), ÇÑõ¿©°ú¹ý.
  • agar layer method
    ÇÑõÁßÃþ¹ý(¡­ñìöµÛö).
  • agar streak method
    ÇÑõȭ¼±¹ý(¡­ûþàÊÛö).
  • albumin method
    ¾ËºÎ¹Î¹ý
  • alkaline phosphatase antialkaline phophatase method
    ¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦ Ç×¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦¹ý
  • allochromatic method
    º¯»ö¹ý.
  • alternate case method
    ±³´ëȯÀÚ¿ä¹ý.
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý(ÎßÓÛÓßí¡ü´íºèþÛö).
  • analytical method
    ºÐ¼®¹ý
  • ascending method
    »ó½Â¹ý
  • aspirative irrigation method
    ÈíÀμ¼Ã´¹ý.
  • auscultatory method
    ûÁø¹ý.
  • bidiazotized benzidine method
    ¹ÙÀ̵ð¾ÆÁ¶È­º¥Áöµò¹ý
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý(¡­ËþïÒÛö).
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý(ÊÙË§ËøËÑ).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • protozoan disease
    ¿øÃæÁúȯ, ¿øÃ溴
  • tropical disease
    ¿­´ëº´, ¿­´ëÁúȯ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Fabry's disease
    ÆÄºê¸® Áúȯ (òðü´)
  • Farber's disease
    ÆÄ¾Æ¹ö Áúȯ(òðü´)
  • Forbe`s disease
    Æ÷ºê Áúȯ(òðü´)
  • Gaucher's disease
    °í¿À¼Å Áúȯ(òðü´)
  • genetic disease
    À¯Àü Áúȯ(ë¶îîòðü´)
  • Gilbert's disease
    ±æ¹öÆ® Áúȯ(òðü´)
  • glycogen storage disease
    ±Û¶óÀÌÄÚÀü ÀúÀå Áúȯ(îÍíúòðü´)
  • Hartnup's disease
    ÇÏÆ®³Ò Áúȯ(òðü´)
  • heavy-chain disease
    Áß(ñì)»ç½½ Áúȯ(òðü´)
  • Hers' disease
    ¿¡¸£½º Áúȯ(òðü´)
  • I-cell disease
    I-¼¼Æ÷ Áúȯ(á¬øàòðü´)
  • immune deficincy disease
    ¸é¿ª °áÇÌ Áúȯ(Øóæ¹ÌÀù¹òðü´)
  • Krabbe's disease
    Å©¶óº£Áúȯ(òðü´)
  • Kwok's disease
    °û Áúȯ(òðü´)
  • lipid storage disease
    ÁöÁúÀúÀåÁúȯ(ò·òõîÍíúòðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulse spray method
    ¸Æµ¿»ìÆ÷¹ý
  • reflection method
    ¹Ý»ç¹ý
  • repetitive pulse method
    ¹Ýº¹ÆÞ½º¹ý
  • transfrontal method
    °æÀüµÎ¹æ¹ý
  • transmission method
    Åõ°ú¹ý
  • uniform insonation method
    ±ÕµîÀ½ÆÄÁ¶»ç¹ý
  • water filled method
    ¹°Ã游¹ý
  • Zebra-stripe imaging method
    ¾ó·è¸»¹«´Ì¿µ»ó¹æ¹ý
  • acquired heart disease
    ÈÄõ¼º½ÉÀåÁúȯ
  • Addison's disease
    ¾Öµð½¼º´
  • air space disease
    °ø°£Áúȯ
  • caisson disease
    ÀáÇÔº´
  • celiac disease
    ¼Ò¾Æ¸¸¼º¼ÒÈ­Àå¾ÖÁõ, ¼Ò¾ÆÁö¹æº¯Áõ, º¹ºÎÁúº´
  • cerebral vascular disease
    ³úÇ÷°üÁúȯ
  • Charcot's disease
    »þ¸£ÄÚº´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RD radial deviation; radiology department; rate difference; Raynaud disease; reaction of degeneration; ...
HI Method Hemagglutination Inhibiting Method; Ç÷±¸ ÀÀÁý ¾ïÁ¦¹ý
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
CHD Chediak-Higashi disease; childhood disease; chronic hemodialysis; congenital or congestive heart dis...
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LAM Lactational Amenorrhea Method
MEM Maximum Entropy Method
MDL method detection limit
D.C.C. dextran coated charcoal method
PAP peroxidase anti peroxidase method
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Charter's method
    Â÷ÅÍ ¹ý
    Ä©¼Ö »ç¿ë¹ýÀÇ Çϳª·Î, ¼ÖÀÌ Ä¡¾Æ¿Í Ä¡Àº¿¡ ´ëÇÏ¿© 45¡Æ·Î Ä¡°ü ÂÊÀ¸·Î ±â¿ï¾îÁö°Ô Çϸ鼭 ¼öÆòÀ» À¯Áö½ÃŰ°í ¼ÖÀÇ ¹ÝÀº Ä¡¾Æ¿¡ ±×¸®°í ¹ÝÀº Ä¡Àº¿¡ ÀÖµµ·Ï ÇÑ ´ÙÀ½, ¾ÆÁÖ ÀÛÀº ¿øÀ» ±×¸®´Â µíÇÑ Áøµ¿ ¿îµ¿À» Áָ鼭 ÇÏ´Â ¹æ¹ý. À½½Ä Â±â¿Í Ä¡°£¿¡ ¼ÖÀÌ µé¾î°¡°Ô µÇ¾î ¸¶»çÁö ¿ªÇÒµµ ÇÑ´Ù.
  • Chopper method
    Chopper ¹ý
  • column diffusion method
    ±âµÕ È®»ê ¹æ¹ý
  • combination method
    ¿¬ÇÕ¹ý
    Àη¹À̳ª Ä¡°ü º¸Ã¶ Á¦ÀÛ¿¡¼­ ¸ðÇü»ó¿¡ ³³ÇüÀ» ÀÏÂ÷·Î ¿Ï¼ºÇÏ¿© ±¸°­³»¿¡ ½ÃÀûÇÏ¿© ½Ã°øÇÏ°í ¸Å¸ôÇÏ¿© ÁÖÁ¶ÇÏ¿© ¾ò´Â °£Á¢¹ý°ú Á÷Á¢¹ýÀ» °â¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • Dehn-Clark`s method
    µ§-Ŭ¶óÅ©¹ý
  • Denis-Leche's method
    µ¥´Ï½º-·¹Ä¡¹ý
    Àü Ȳȭ¹°ÀÇ °ËÃâ¹ýÀ¸·Î, »êÀ» °¡ÇØ ºÎÆÐÇÑ ´Ü¹éÁúÀ» Á¦°ÅÇÏ°í ¿°È­ ¹Ù·ý¿¡ ÀÇÇØ ħÀü °ÇÁ¶½ÃŲ ÈÄ Äª·®ÇÑ´Ù.
  • diffusion method
    È®»ê¹ý
  • direct method
    Á÷Á¢¹ý
    ȯÀÚÀÇ ±¸°­³»¿¡¼­ ¿Î½º Á¶°¢ÇÏ¿© ³³ ¿øÇüÀ» ¾ò¾î ¸Å¸ôÇϰí ÁÖÁ¶ÇÏ¿© Àη¹À̳ª Ä¡°ü º¸Ã¶¹°À» ¾ò´Â ¹æ¹ýÀÌ´Ù.
  • discomfort with this imaging method
    ÃÔ¿µ½Ã ºÒÆí°¨
  • double investing method
    ÀÌÁß ¸Å¸ô¹ý
  • draining method
    ¹è³ó¹ý, È긮´Â ¹æ¹ý
    »óó, ±Ë¾ç, °øµ¿¿¡¼­ ¾×ü³ª ¹è¼³¹°À» ü°èÀûÀ¸·Î ¹èÃâ½ÃŰ´Â °Í.
  • dye dilution method
    »ö¼Ò Èñ¼®¹ý
  • electromyogram biofeedback method
    ±ÙÀüµµ ¹ÙÀÌ¿ÀÇǵå¹é¹ý
    ¹ÙÀÌ¿ÀÆÐµå¹éÀÇ ÁöÇ¥·Î ±ÙÀüµµ¸¦ »ç¿ëÇÏ´Â °ÍÀÌ°í ±Ù·Â Áõ°­ ÈÆ·Ã°ú ±Ù ÀÌ¿Ï ÈÆ·Ã°ú´Â ÀüÇô ¹Ý´ëÀÇ Ä¡·á¹ýÀ¸·Î ÇÔ²² ÀÌ¿ëµÈ´Ù. ±Ù·Â Áõ°­ ÈÆ·ÃÀ¸·Î¼­´Â ¸»ÃÊ½Å°æ ¸¶ºñ, ³úÁ¹Áß, ³ú¼º ¸¶ºñ µî¿¡ »ç¿ëµÇ°í ±ÙÀÌ¿Ï ÈÆ·ÃÀ¸·Î¼­´Â »ç°æ µî¿¡ »ç¿ëµÈ´Ù.
  • expansion method
    ÆØÃ¢ ¹æ¹ý
    ¸Å¸ôÀçÀÇ °æÈ­ ÆØÃ¢, °¡¿­ ÆØÃ¢À» ÀÌ¿ëÇϰųª ¸ðÇü Àç·áÀÇ °æÈ­ ÆØÃ¢À» ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • fast gradient recalled echo method
    °í¼Ó °æ»ç ȸº¹ ¿¡ÄÚ ±â¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
Born method Wax plate reconstruction, the making of three-dimensional models of structures from serial sections; it depends on the building up of a series of wax plates, cut out to scaled enlargements of the individual sections involved in the region to be reconstructed.
(05 Mar 2000)
Bradford method <investigation> Method for determining protein concentration based upon the binding of Coomassie Brilliant Blue to protein and consequent shift in absorption maximum of the dye.
(18 Nov 1997)
Brasdor's method Treatment of aneurysm by ligation of the artery immediately below (on the distal side of) the tumour.
(05 Mar 2000)
Callahan's method A method of filling the root canals of teeth by dissolving gutta-percha cones in a chloroform-rosin medium within the root canal.
Synonym: Callahan's method, Johnson's method.
(05 Mar 2000)
capture-recapture method Originally, a technique developed by biologists to track wild animal populations; now adapted for epidemiological studies of elusive human populations (e.g., prostitutes, teen runaways, IV drug users).By comparing data from several independent overlapping sample frames, it is possible to adjust for missing cases and to generate estimates of the prevalence of a given condition, for example, AIDS infection.
(05 Mar 2000)
Pachon's method Cardiography, carried out with the patient lying on the left side.
(05 Mar 2000)
macro-Kjeldahl method A procedure for analyzing the content of nitrogenous compounds in urine, serum, or other specimens, usually to determine relatively large amounts of nitrogen (e.g., 20 to 100 mg); the specimen is treated with a digestion mixture (copper sulfate and sulfuric acid), heated thoroughly, and made alkaline with a solution of sodium hydroxide; ammonia is then distilled from the mixture, trapped in a boric acid-indicator solution, and titrated with standard hydrochloric or sulfuric acid.
(05 Mar 2000)
Gartner's method A method of measuring venous pressure, based upon Gartner's vein phenomenon; with the patient sitting erect, a vein is selected on the back of the hand which is held dependent, well below the level of the right atrium, and then is raised slowly; when the vein is observed to collapse, the distance between its level and that of the atrium is measured with a millimeter rule; this distance gives the venous pressure in millimeters of blood; thus the vein itself is used as a manometer communicating with the right atrium; highly inaccurate, especially in elderly subjects.
(05 Mar 2000)
paracelsian method The use of chemical agents only in the treatment of disease.
(05 Mar 2000)
parallax method Localization of a foreign body by observing the direction of its motion on a fluoroscopic screen while moving the X-ray tube or the screen.
(05 Mar 2000)
Marshall's method A quantitative procedure for estimating free and conjugated sulfanilamide in body fluids.
(05 Mar 2000)
Carpue's method Rhinoplasty utilizing a flap from the forehead.
Synonym: Carpue's method, Indian method, Indian operation.
(05 Mar 2000)
Gerota's method Injection of the lymphatics with a dye that is soluble in chloroform or ether but not in water; alkannin, red sulfide of mercury, and Prussian blue are said to be suitable for this purpose.
(05 Mar 2000)
reference method An analytical procedure sufficiently free of random or systematic error to make it useful for validating proposed new analytical procedures for the same analyte.
(05 Mar 2000)
Maxam Gilbert method A method of DNA sequencing, based on the controlled degradation of a DNA fragment in a set of independent, nucleotide specific reactions. The resulting fragments have characteristic sizes depending on the sequence of the template, that can be resolved on a sequencing gel. Although no longer the main protocol, Maxam Gilbert sequencing still has advantages, for example for oligonucleotides or covalently modified DNA.
See: dideoxy sequencing.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • field method
    ¾ß¿Ü ¿¬±¸¹ý !
  • graduated length method
    Á¡Â÷Àû ±æÀÌ º¯°æ¹ý(±â¼úÀÇ Çâ»ó¿¡ µû¶ó ½ºÅ°¸¦ ±ä °ÍÀ¸·Î Á¡Â÷ ¹Ù²Ù¾î °¡´Â ½ºÅ° Áöµµ¹ý)
  • method
    ¹æ¹ý;¹æ½Ä;(±ÔÄ¢¹Ù¸¥)¼ø¼­;Áú¼­
  • project method
    ±¸¾È ±³¼ö¹ý(ÇлýÀÇ µÎ³ú Ȱµ¿°ú ÀÛ¾÷À» ¿ä±¸ÇÏ´Â ½Ç¹° ±³¼ö)
  • rhythm method
    ÁÖ±â ÇÇÀÓ¹ý 6
  • disease
    º´,Áúȯ
  • Creutzfeldt-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®¾ßÄߺ´
  • DUST DISEASE
    =PNEUNOCONIOSIS
  • Dutch elm disease
    (½Ä)¼¼±Õ¼ºÀÇ ´À¸¨³ª¹«º´
  • English disease
    ¿µ±¹º´(³ëµ¿ÀÚÀÇ Å¾÷¿¡ ÀÇÇÑ »ý»ê ÀúÇÏ µîÀÇ »çȸÀû º´Æó);(°í)±¸·çº´;±â°üÁö¿°
  • Fabry's disease
    ÆÄºê¸®º´(¼±Ãµ¼º ÁöÁú ´ë»ç ÀÌ»óÁõ)
  • GVH disease
    ´ë¼÷ÁÖ¼º ÀÌ½ÄÆíº´
  • Graves' disease
    ±×·¹À̺êÁî(¹ÙÁ¦µµ)º´
  • Hansens disease
    ÇѼ¾º´;¹®µÕº´
  • Hashimoto's disease
    ÇϽø𵵺´;¸¸¼º °©»ó¼±¿°(°©»ó¼± ±â´ÉÀÌ ÀúÇϵǴ Áúȯ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á